AP NEWS

Global Hemorrhagic Stroke Treatment Market 2019-2023 | Rising Incidence in Aging Population to Boost Demand | Technavio

January 4, 2019

LONDON--(BUSINESS WIRE)--Jan 4, 2019-- analysts forecast the global hemorrhagic stroke treatment market to have an incremental growth of USD 162 million during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190104005157/en/

Technavio forecasts the global hemorrhagic stroke treatment market to have an incremental growth of USD 162 million by 2022. (Graphic: Business Wire)

Improved diagnostic modalities is one of the major trends being witnessed in the . For the appropriate management of hemorrhagic stroke treatment, an adequate understanding of diagnostic modalities and parenchymal hemorrhagic is crucial. There are advanced diagnostic facilities and diagnostic modalities that not only help neurologists in hemorrhagic stroke treatment to identify the type of stroke but also help in designing the drug therapy for the management of disease, thereby helping in overcoming the shortcomings. Thus, improved diagnostic modalities help to drive the market for hemorrhagic stroke treatment.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global hemorrhagic stroke treatment market is the rising incidence in an aging population:

Global hemorrhagic stroke treatment market: Rising incidence in the aging population

Increasing age is a major risk factor for several conditions, including intracerebral hemorrhages. The natural and pathological changes that occur with aging population make the cardiovascular system and the CNS more prone to stroke. To address the increasing number of conditions among the aging population, pharmacotherapy is being extensively used as a treatment option, and the same applies to the treatment of stroke. There is a huge demand for drugs under this section, especially by the elderly, which is a major factor driving market growth.

According to a senior analyst at Technavio, “The hemorrhagic stroke is quite evident in the aging population. Cerebral amyloid angiopathy (CAA), regarded as an age-related disease characterized by the deposition of amyloid inside the walls of the blood vessels, is known to be associated with intracerebral hemorrhage. As per recent estimates, the percentage of intracerebral hemorrhage cases linked to CAA is as high as 50% among the elderly.”

Global hemorrhagic stroke treatment market: Segmentation analysis

The global hemorrhagic stroke treatment market research report provides market segmentation by product (antihypertensives, anticoagulants, diuretics, anticonvulsants, and others) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The Americas held the largest share of the market in 2018, accounting for more than 38% share. It was followed by APAC and EMEA respectively. The dominance of the Americas can be attributed to the rising incidence in the aging population and increasing prevalence of hypertension.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20190104005157/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: SENIORS HEALTH PHARMACEUTICAL OTHER HEALTH CONSUMER

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 01/04/2019 05:03 AM/DISC: 01/04/2019 05:03 AM

http://www.businesswire.com/news/home/20190104005157/en

AP RADIO
Update hourly